Five most commonly used types of pharmaceuticals
Waldron, C.J.; Poisal, J.A.
Health Care Financing Review 20(3): 119-123
1999
ISSN/ISBN: 0195-8631 PMID: 10558016 Document Number: 509446
Document emailed within 1 workday
Related Documents
McKenzie, N.D.; Kobetz, E.N.; Hnatyszyn, J.; Twiggs, L.B.; Lucci, J.A. 2010: Women with HIV are more commonly infected with non-16 and -18 high-risk HPV types Gynecologic Oncology 116(3): 572-577Dogra, J.; Lal, B.B.; Misra, S.N. 1989: Cutaneous Leishmaniasis: Therapeutic Efficacy of Dapsone in the Commonly Existing Sub-types Indian Journal of Dermatology Venereology and Leprology 55(6): 375-377
Gouveia, W.A. 1993: The rising cost of pharmaceuticals: understanding and managing the escalating cost of pharmaceuticals in health care institutions. Executive summary American Journal of Hospital Pharmacy 50(8 Suppl. 4): S2-S3
Lobb, W.B.; Wilkin, N.E.; Holmes, E.R. 2015: Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: a Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States International Journal of Pharmaceutical Compounding 19(6): 514-520
Chouinard, J.L. 1981: Emergency medicine: two types of practice, three types of recognition? Canadian Medical Association Journal 125(3): 235
Conor, R.A.; Feldman, R.D.; Dowd, B.E. 1997: Which types of hospital mergers save consumers money ? - Quelles sont les types de fusions d'hôpitaux qui font économiser de l'argent au consommateur ? Health Affairs (Millwood, Va) 16(6): 62-74
Haddad, J.J. 2001: VX-745. Vertex Pharmaceuticals Current Opinion in Investigational Drugs 2(8): 1070-1076
Smith, P.F. 2004: GW-1000. GW Pharmaceuticals Current Opinion in Investigational Drugs 5(7): 748-754
Eder, D.N. 2002: CEE-03-310 CeNeS pharmaceuticals Current Opinion in Investigational Drugs 3(2): 284-288
2013: Most prescribed pharmaceuticals Modern Healthcare 43(28): 34
Lim, M.L. 2001: DPC-083. DuPont Pharmaceuticals Current Opinion in Investigational Drugs 2(9): 1209-1212
Malik, P. 2002: Promises kept and broken: new pharmaceuticals Canadian Journal of Cardiology 18(5): 493-494
Ahsan, S.S.; Blaug, S.M. 1960: Interactions of tweens with some pharmaceuticals Drug Standards 28: 95-100
Taupin, P. 2006: OTI-010 Osiris Therapeutics/JCR Pharmaceuticals Current Opinion in Investigational Drugs 7(5): 473-481
Jankel, C.A. 1990: Evaluating effectiveness of pharmaceuticals American Journal of Hospital Pharmacy 47(7): 1633-1635
Le Pen, C. 2015: Pharmaceuticals: is there a just price for innovation? La Revue du Praticien 65(9): 1141-1145
Konieczny, M.T. 2000: Patent protection of pharmaceuticals Acta Poloniae Pharmaceutica 57 Suppl: 84-87
Dey, S. 2002: Biricodar. Vertex Pharmaceuticals Current Opinion in Investigational Drugs 3(5): 818-823
Plempel, M. 1981: New pharmaceuticals in systemic mycoses Zeitschrift für Hautkrankheiten 56(17): 1109-1125
Dangor, C.M.; Veltman, A.M. 1986: Sugar-free liquid pharmaceuticals South African Medical Journal 70(4): 199-200